S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in
NYSE:LCI

Lannett Stock Forecast, Price & News

$6.70
-0.16 (-2.33 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$6.67
Now: $6.70
$6.96
50-Day Range
$6.16
MA: $6.58
$6.95
52-Week Range
$4.89
Now: $6.70
$10.34
Volume268,753 shs
Average Volume287,095 shs
Market Capitalization$279.39 million
P/E RatioN/A
Dividend YieldN/A
Beta1.31
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Posaconazole DR tablets, Verapamil SR tablets, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Metolazone tablets, Amphetamine IR Tablets, Methylphenidate Hydrochloride ER stimulants, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Pharm Group, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was founded in 1942 and is headquartered in Philadelphia, Pennsylvania.
Lannett logo

MarketRank

Overall MarketRank

1.97 out of 5 stars

Medical Sector

49th out of 1,557 stocks

Pharmaceutical Preparations Industry

20th out of 638 stocks

Analyst Opinion: 3.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 2.5 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP51601210
Phone215-333-9000
Employees954

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$545.74 million
Cash Flow$2.56 per share
Book Value$7.51 per share

Profitability

Net Income$-33,370,000.00

Miscellaneous

Market Cap$279.39 million
Next Earnings Date2/3/2021 (Estimated)
OptionableOptionable
$6.70
-0.16 (-2.33 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LCI News and Ratings via Email

Sign-up to receive the latest news and ratings for LCI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Lannett (NYSE:LCI) Frequently Asked Questions

How has Lannett's stock price been impacted by COVID-19?

Lannett's stock was trading at $7.74 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, LCI shares have decreased by 13.4% and is now trading at $6.70.
View which stocks have been most impacted by COVID-19
.

Is Lannett a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Lannett in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Lannett stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LCI, but not buy additional shares or sell existing shares.
View analyst ratings for Lannett
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Lannett?

Wall Street analysts have given Lannett a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Lannett wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Lannett's next earnings date?

Lannett is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021.
View our earnings forecast for Lannett
.

How were Lannett's earnings last quarter?

Lannett Company, Inc. (NYSE:LCI) posted its quarterly earnings data on Wednesday, November, 4th. The company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.10 by $0.04. The company had revenue of $126.48 million for the quarter, compared to the consensus estimate of $128.94 million. Lannett had a positive return on equity of 12.62% and a negative net margin of 5.09%. The firm's revenue for the quarter was down .7% on a year-over-year basis. During the same period in the prior year, the business earned $0.22 earnings per share.
View Lannett's earnings history
.

What guidance has Lannett issued on next quarter's earnings?

Lannett issued an update on its FY 2021 After-Hours earnings guidance on Wednesday, November, 4th. The company provided EPS guidance of for the period. The company issued revenue guidance of $520-545 million, compared to the consensus revenue estimate of $537.17 million.

What price target have analysts set for LCI?

3 brokers have issued 12 month price objectives for Lannett's shares. Their forecasts range from $6.00 to $11.00. On average, they expect Lannett's stock price to reach $8.50 in the next year. This suggests a possible upside of 26.9% from the stock's current price.
View analysts' price targets for Lannett
or view Wall Street analyst' top-rated stocks.

Who are some of Lannett's key competitors?

What other stocks do shareholders of Lannett own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lannett investors own include (CELG), Akorn (AKRX), Skechers U.S.A. (SKX), Integrated Device Technology (IDTI), Bank of America (BAC), Alibaba Group (BABA), Gilead Sciences (GILD), Micron Technology (MU), Rite Aid (RAD) and NVIDIA (NVDA).

Who are Lannett's key executives?

Lannett's management team includes the following people:
  • Mr. Timothy C. Crew, CEO & Director (Age 59, Pay $2.13M)
  • Mr. John Kozlowski, VP of Fin., CFO & Principal Accounting Officer (Age 48, Pay $926.75k)
  • Mr. John M. Abt, VP and Chief Quality & Operations Officer (Age 55, Pay $898.59k)
  • Mr. Samuel H. Israel, Gen. Counsel & Chief Legal Officer (Age 58, Pay $1.06M)
  • Ms. Maureen M. Cavanaugh, Sr. VP & Chief Commercial Operations Officer (Age 61, Pay $1.1M)
  • Mr. Robert Ehlinger, VP & Chief Information Officer (Age 63)
  • Ms. Kristie Stephens, Chief Compliance Officer & VP of Regulatory Affairs
  • Mr. Grant Brock, VP of Operations

What is Lannett's stock symbol?

Lannett trades on the New York Stock Exchange (NYSE) under the ticker symbol "LCI."

Who are Lannett's major shareholders?

Lannett's stock is owned by many different institutional and retail investors. Top institutional investors include State of Alaska Department of Revenue (0.06%) and Crossmark Global Holdings Inc. (0.04%). Company insiders that own Lannett stock include Albert Paonessa III, David A Drabik, Jeffrey Farber, Patrick G Lepore and Timothy C Crew.
View institutional ownership trends for Lannett
.

Which institutional investors are selling Lannett stock?

LCI stock was sold by a variety of institutional investors in the last quarter, including Crossmark Global Holdings Inc., and State of Alaska Department of Revenue.
View insider buying and selling activity for Lannett
or view top insider-selling stocks.

How do I buy shares of Lannett?

Shares of LCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Lannett's stock price today?

One share of LCI stock can currently be purchased for approximately $6.70.

How big of a company is Lannett?

Lannett has a market capitalization of $279.39 million and generates $545.74 million in revenue each year. The company earns $-33,370,000.00 in net income (profit) each year or $1.07 on an earnings per share basis. Lannett employs 954 workers across the globe.

What is Lannett's official website?

The official website for Lannett is www.lannett.com.

How can I contact Lannett?

Lannett's mailing address is 9000 STATE ROAD, PHILADELPHIA PA, 19136. The company can be reached via phone at 215-333-9000.

This page was last updated on 1/16/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.